← Back to Search

Local Anesthetic

Pre-operative femoral nerve catheter for Postoperative Pain

Phase 3
Waitlist Available
Research Sponsored by Rothman Institute Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial is evaluating whether a single injection of liposomal bupivacaine (Exparel) into the adductor canal is a safe and effective alternative to a femoral nerve catheter for post-operative pain control in patients undergoing ACL reconstruction.

Eligible Conditions
  • Anterior Cruciate Ligament (ACL)
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient satisfaction
Post operative pain management

Trial Design

2Treatment groups
Active Control
Group I: Pre-operative femoral nerve catheterActive Control4 Interventions
participants undergoing ACL reconstruction surgery will receive a femoral prior to their surgery
Group II: Pre-operative adductor canal block with liposomal bupivacaineActive Control4 Interventions
participants undergoing ACL reconstruction surgery will receive a nerve block using liposomal Bupivacaine (Exparel)

Find a Location

Who is running the clinical trial?

Rothman Institute OrthopaedicsLead Sponsor
121 Previous Clinical Trials
21,424 Total Patients Enrolled
3 Trials studying Postoperative Pain
523 Patients Enrolled for Postoperative Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any other similar research projects to the Pre-operative adductor canal block with liposomal bupivacaine clinical trial?

"In total, 236 studies are being conducted to explore the efficacy of Pre-operative adductor canal block with liposomal bupivacaine. Of these, 54 are in Phase 3 and 1190 clinical trial sites are operational. Most of these trials originate from Germantown, Tennessee."

Answered by AI

What type of surgery is Pre-operative adductor canal block with liposomal bupivacaine used for?

"Permphigus can be treated with a pre-operative adductor canal block that uses liposomal bupivacaine. This medical intervention can also help patients struggling with catarrh, lupus erythematosus cell, and ulcerative colitis."

Answered by AI

What is the total sample size for this clinical trial?

"Presently, this particular trial is not recruiting patients. Although, it was initially posted on December 6th 2021 and updated less than a week ago on December 3rd. There are 545 other clinical trials focused on pain and postoperative care that are actively admitting patients right now. Additionally, there are 236 trials centered around Pre-operative adductor canal block with liposomal bupivacaine admitting patients as well."

Answered by AI

Is it legally allowed to use Pre-operative adductor canal block with liposomal bupivacaine?

"Pre-operative adductor canal block with liposomal bupivacaine has received a score of 3 for safety. This is based on the fact that it is a Phase 3 trial, meaning there is some data supporting efficacy and multiple rounds of data supporting safety."

Answered by AI

Is this research study still looking for volunteers?

"Unfortunately, this study is not currently looking for new patients. Although, according to the latest update on 12/3/2021, this may change in the future. If you are interested in other studies, 545 trials for pain management and 236 trials for Pre-operative adductor canal block with liposomal bupivacaine are both actively recruiting participants."

Answered by AI
~46 spots leftby Apr 2025